DaVita Inc. (DVA) company profile

DaVita Inc. provides comprehensive kidney care services to individuals suffering from chronic kidney disease and end-stage kidney disease. Its core operations encompass outpatient hemodialysis, hospital inpatient hemodialysis, home-based peritoneal and hemodialysis support, and specialized clinical laboratory testing. Beyond direct dialysis treatments, the company delivers integrated kidney care programs coordinating patient management across the disease continuum, clinical research services, and transplant management software. Its customers primarily include kidney disease patients, commercial health plans, hospitals, and government healthcare programs such as Medicare and Medicaid.

Operating across an extensive network, the company delivers care through 2,657 outpatient dialysis centers across 46 U.S. states and the District of Columbia, in addition to service contracts with approximately 740 hospitals nationwide. Internationally, it supports 585 outpatient centers across 14 countries outside the United States. The text does not state the location of the company's headquarters.

Summary of the business section of DaVita's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“As of December 31, 2025, we employed approximately 78,000 teammates, including our international teammates, with approximately 72% of our teammates located within the U.S.”